Avera Research Grand Rounds, November 2019 (Enduring Material)

Instructions to Receive Credit

Date & Location
Tuesday, January 28, 2020, 8:00 AM - Tuesday, December 15, 2020, 5:00 PM

Overview
Upon completion of this activity, the learner will have better cooperative interactions and improved communication and understanding of ongoing research among investigators within Avera.

Target Audience
Specialties - Other
Professions - Nurse - RN, Physician

ACCME Objectives
  1. Recognize tumor heterogeneity and the development of treatment resistance through comprehensive genomic testing
  2. Recognize the benefits of transcriptome profiling

ANCC Learning Outcomes
  1. Recognize tumor heterogeneity and the development of treatment resistance through comprehensive genomic testing
  2. Recognize the benefits of transcriptome profiling

Additional Information
ADA accommodations will be made in accordance with the law. If you require ADA accommodations, please indicate what your needs are at the time of registration. We cannot ensure the availability of appropriate accommodations without prior notification.

Accreditation

Avera is accredited by the Accreditation Council for Continuing Medical Education to provide continuing education for physicians. Avera designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit per session. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Avera is an Approved Provider of continuing nursing education by the Alabama State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. A total 1.0 contact hours can be received upon completion of this activity. Attendance at the entire educational activity is required to receive contact hours.

The South Dakota Board of Pharmacy has approved this educational activity for 1.0 continuing education hours for pharmacists.

 


Keywords: PharmSDResearch